Ainos, Inc. (AIMDW)

Market Cap	16.12M
Revenue (ttm)	110,870
Net Income (ttm)	-15.72M
Shares Out	4.66M
EPS (ttm)	-5.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,353
Open	0.5000
Previous Close	0.4601
Day's Range	0.4501 - 0.5509
52-Week Range	0.0250 - 0.9490
Beta	2.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About AIMDW

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMDW
• Website: https://www.ainos.com